Griffin Health lanserar sitt frameless SRS program där de använder C-RAD Catalyst HD med C-RADs cBrain mjukvara

by NASDAQ Market News February 15, 2019

NASDAQ Market News
Click here to email author

Updated Results from Phase 1 Study of Telaglenastat (CB-839) to be Presented at 2019 ASCO Genitourinary Cancer Symposium

Humanigen Study of GM-CSF Neutralization With CAR-T Therapy Selected for Front Cover of Current Edition of ‘blood’®, The Official Journal of the American Society of Hematology (ASH)

Ads